Pages that link to "Q80914792"

The following pages link to Introduction: The burden of hepatocellular carcinoma (Q80914792):

Displaying 23 items.

• Role of endoscopic ultrasound in diagnosis and management of hepatocellular carcinoma (Q27336354) (← links)
• Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model (Q28484915) (← links)
• The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology (Q30447686) (← links)
• Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma (Q33802709) (← links)
• Symptom management in hepatocellular carcinoma (Q33897458) (← links)
• NF-κB and STAT3 – key players in liver inflammation and cancer (Q35347976) (← links)
• Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma (Q35600888) (← links)
• Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases (Q36897895) (← links)
• Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. (Q37157400) (← links)
• Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma (Q37285005) (← links)
• Imaging of hepatocellular carcinoma and image guided therapies - how we do it. (Q37680183) (← links)
• Irreversible electroporation of hepatic malignancy (Q38179347) (← links)
• Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care? (Q38252622) (← links)
• Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma (Q38447648) (← links)
• Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities (Q38935703) (← links)
• Anticancer potential of rhamnocitrin 4'-β-D-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats. (Q43778437) (← links)
• Hypoxia induces the expression of TET enzymes in HepG2 cells (Q47146112) (← links)
• Primary Care Providers Report Challenges to Cirrhosis Management and Specialty Care Coordination (Q48104141) (← links)
• CD8+ T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma. (Q55243718) (← links)
• Oncogenic Signaling Induced by HCV Infection (Q57050806) (← links)
• Inflammation-induced LINC00665 increases the malignancy through activating PKR/NF-κB pathway in hepatocellular carcinoma (Q89828861) (← links)
• Knowledge, Attitudes, and Behaviors of Viral Hepatitis Among Recent African Immigrants in the United States: A Community Based Participatory Research Qualitative Study (Q90642977) (← links)
• Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging (Q95276807) (← links)